MISSION THERAPEUTICS LIMITED

Organization

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compounds
- Patent number 11,993,595
- Issue date May 28, 2024
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,958,833
- Issue date Apr 16, 2024
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-cyano-pyrrolidine derivatives as dub inhibitors
- Patent number 11,945,797
- Issue date Apr 2, 2024
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhi...
- Patent number 11,414,402
- Issue date Aug 16, 2022
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-cyano-pyrrolidine compounds as USP30 inhibitors
- Patent number 11,390,584
- Issue date Jul 19, 2022
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyano-substituted heterocycles with activity as inhibitors of USP30
- Patent number 11,370,784
- Issue date Jun 28, 2022
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-cyano-pyrrolidine derivatives as DUB inhibitors
- Patent number 11,352,339
- Issue date Jun 7, 2022
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
- Patent number 11,319,287
- Issue date May 3, 2022
- MISSION THERAPEUTICS LIMITED
- Mark Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates f...
- Patent number 11,306,096
- Issue date Apr 19, 2022
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes...
- Patent number 11,236,092
- Issue date Feb 1, 2022
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,130,748
- Issue date Sep 28, 2021
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-cyano-pyrrolidine derivatives as inhibitors of USP30
- Patent number 11,091,488
- Issue date Aug 17, 2021
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyanopyrrolidine derivatives with activity as inhibitors of USP30
- Patent number 11,084,821
- Issue date Aug 10, 2021
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-cyano-pyrrolidine compounds as USP30 inhibitors
- Patent number 11,066,365
- Issue date Jul 20, 2021
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted cyanopyrrolidines with activity as DUB inhibitors
- Patent number 11,059,809
- Issue date Jul 13, 2021
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-cyano-pyrrolidine compounds as USP30 inhibitors
- Patent number 11,053,198
- Issue date Jul 6, 2021
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyanopyrrolidine derivatives with activity as inhibitors of USP30
- Patent number 11,014,912
- Issue date May 25, 2021
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyano-subtituted heterocycles with activity as inhibitors of USP30
- Patent number 10,927,110
- Issue date Feb 23, 2021
- MISSION THERAPEUTICS LIMITED
- Martin Lee Stockley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-cyano-pyrrolidine compounds as USP30 inhibitors
- Patent number 10,689,345
- Issue date Jun 23, 2020
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of screening and treatment with USP4 inhibitors
- Patent number 10,690,656
- Issue date Jun 23, 2020
- MISSION THERAPEUTICS LIMITED
- Xavier Jacq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-cyanoisoindoline derivatives for treating cancer
- Patent number 10,683,269
- Issue date Jun 16, 2020
- MISSION THERAPEUTICS LIMITED
- Karl Richard Gibson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
- Patent number 10,669,234
- Issue date Jun 2, 2020
- MISSION THERAPEUTICS LIMITED
- Mark Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes...
- Patent number 10,654,853
- Issue date May 19, 2020
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 10,640,498
- Issue date May 5, 2020
- MISSION THERAPEUTICS LIMITED
- Karl Richard Gibson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyanopyrrolidine derivatives as inhibitors for DUBs
- Patent number 10,590,075
- Issue date Mar 17, 2020
- MISSION THERAPEUTICS LIMITED
- Mark Ian Kemp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methodologies for measuring isopeptidase activity in biological sam...
- Patent number 10,527,610
- Issue date Jan 7, 2020
- MISSION THERAPEUTICS LIMITED
- Xavier Jacq
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds
- Patent number 10,392,380
- Issue date Aug 27, 2019
- MISSION THERAPEUTICS LIMITED
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-cyano-pyrrolidine compounds as USP30 inhibitors
- Patent number 10,343,992
- Issue date Jul 9, 2019
- Missions Therapeutics Limited
- Alison Jones
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRR...
- Publication number 20230312580
- Publication date Oct 5, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20230303547
- Publication date Sep 28, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-...
- Publication number 20230219939
- Publication date Jul 13, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20230119013
- Publication date Apr 20, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20230052191
- Publication date Feb 16, 2023
- Mission Therapeutics Limited
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20220315572
- Publication date Oct 6, 2022
- Mission Therapeutics Limited
- Paul William THOMPSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
- Publication number 20220251041
- Publication date Aug 11, 2022
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS
- Publication number 20220177451
- Publication date Jun 9, 2022
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...
- Publication number 20220106315
- Publication date Apr 7, 2022
- Mission Therapeutics Limited
- Mark KEMP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30
- Publication number 20210284631
- Publication date Sep 16, 2021
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4,6 DIHYDROPYRROLO [3,4-C] PYRAZOLE-5 (1H)-CARBONITRILE DERIVATES F...
- Publication number 20210221813
- Publication date Jul 22, 2021
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT
- Publication number 20210002262
- Publication date Jan 7, 2021
- Mission Therapeutics Limited
- Paul William THOMPSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20200369658
- Publication date Nov 26, 2020
- Mission Therapeutics Limited
- Alison Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS
- Publication number 20200331888
- Publication date Oct 22, 2020
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE DERIVATIVES AS INHIBITORS OF USP30
- Publication number 20200262838
- Publication date Aug 20, 2020
- MISSION THERAPEUTICS LIMITED
- Mark Ian KEMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...
- Publication number 20200247803
- Publication date Aug 6, 2020
- Mission Therapeutics Limited
- Mark Ian KEMP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20200231542
- Publication date Jul 23, 2020
- Mission Therapeutics Limited
- Mark KEMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYANOPYRROLIDINE DERIVATIVES WITH ACTIVITY AS INHIBITORS OF USP30
- Publication number 20200199126
- Publication date Jun 25, 2020
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
- Publication number 20200181086
- Publication date Jun 11, 2020
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds
- Publication number 20200172516
- Publication date Jun 4, 2020
- Mission Therapeutics Limited
- Mark Ian KEMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFONAMIDE-SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHI...
- Publication number 20200172518
- Publication date Jun 4, 2020
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHIBITORS
- Publication number 20200172519
- Publication date Jun 4, 2020
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANOPYRROLIDINE DERIVATIVES WITH ACTIVITY AS INHIBITORS OF USP30
- Publication number 20200017480
- Publication date Jan 16, 2020
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
- Publication number 20190322624
- Publication date Oct 24, 2019
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
- Publication number 20190284138
- Publication date Sep 19, 2019
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
- Publication number 20190270708
- Publication date Sep 5, 2019
- Mission Therapeutics Limited
- Alison JONES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANO-SUBTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30
- Publication number 20190218215
- Publication date Jul 18, 2019
- Mission Therapeutics Limited
- Martin Lee STOCKLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20190055232
- Publication date Feb 21, 2019
- Mission Therapeutics Limited
- Karl Richard GIBSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...
- Publication number 20190048008
- Publication date Feb 14, 2019
- Mission Therapeutics Limited
- Mark Ian KEMP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SCREENING AND TREATMENT WITH USP4 INHIBITORS
- Publication number 20190033292
- Publication date Jan 31, 2019
- Mission Therapeutics Limited
- Xavier JACQ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
85528296 - MISSION THERAPEUTICS
- Serial number 85528296
- Filing date Jan 30, 2012
- Mission Therapeutics Limited
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

MISSION THERAPEUTICS LIMITED

Organization

Patents Grantslast 30 patents

Compounds

Compounds

1-cyano-pyrrolidine derivatives as dub inhibitors

Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhi...

1-cyano-pyrrolidine compounds as USP30 inhibitors

Cyano-substituted heterocycles with activity as inhibitors of USP30

1-cyano-pyrrolidine derivatives as DUB inhibitors

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates f...

Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes...

Compounds

1-cyano-pyrrolidine derivatives as inhibitors of USP30

Cyanopyrrolidine derivatives with activity as inhibitors of USP30

1-cyano-pyrrolidine compounds as USP30 inhibitors

Substituted cyanopyrrolidines with activity as DUB inhibitors

1-cyano-pyrrolidine compounds as USP30 inhibitors

Cyanopyrrolidine derivatives with activity as inhibitors of USP30

Cyano-subtituted heterocycles with activity as inhibitors of USP30

1-cyano-pyrrolidine compounds as USP30 inhibitors

Methods of screening and treatment with USP4 inhibitors

2-cyanoisoindoline derivatives for treating cancer

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes...

Compounds

Cyanopyrrolidine derivatives as inhibitors for DUBs

Methodologies for measuring isopeptidase activity in biological sam...

Compounds

1-cyano-pyrrolidine compounds as USP30 inhibitors

Patents Applicationslast 30 patents

1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRR...

N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-...

N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

NOVEL COMPOUNDS

SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS

SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...

CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30

4,6 DIHYDROPYRROLO [3,4-C] PYRAZOLE-5 (1H)-CARBONITRILE DERIVATES F...

CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT

NOVEL COMPOUNDS

1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS

1-CYANO-PYRROLIDINE DERIVATIVES AS INHIBITORS OF USP30

SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...

CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER

CYANOPYRROLIDINE DERIVATIVES WITH ACTIVITY AS INHIBITORS OF USP30

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

Novel Compounds

SULFONAMIDE-SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHI...

SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHIBITORS

CYANOPYRROLIDINE DERIVATIVES WITH ACTIVITY AS INHIBITORS OF USP30

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

CYANO-SUBTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30

NOVEL COMPOUNDS

SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES...

METHODS OF SCREENING AND TREATMENT WITH USP4 INHIBITORS

Trademarklast 30 trademarks

85528296 - MISSION THERAPEUTICS